Ms. LW MF2 Hematology
Activity
Tutorial
Tutorial
Part 1: You are working in the Red Blood Cell Disorders Clinic at McMaster. You are asked to see Ms. LW by your preceptor for routine follow up. Ms. LW is a 43-year-old cisgender woman who was diagnosed with sickle cell disease as a child while living in Guyana. Part 2: It is a few months later and you are on a rotation working in the emergency department. You see Ms. LW’s name on the tracker and remember seeing her in the RBC Disorders Clinic. You pull the triage assessment and read that Ms. LW is presenting with a 2-day history of jaundice and pain in her arms and back, which has been unresponsive to oral hydromorphone at home. Vitals in triage reveal HR 110, BP 110/65, T 36°C, RR 16, SpO2 99% on room air.
Curriculum Block
Hematology / Medical Foundation 2 / Part 2 / Week 2
- Indicates most relevant
Objectives
General Objectives
- Describe the normal production and destruction of hemoglobin.
- Describe the genetics and molecular structure of hemoglobin, its synthesis and how qualitative and quantitative abnormalities cause disease.
- Describe the destruction of hemoglobin and bilirubin metabolism especially in relation to hemolytic disorders.
- Explain the affinity of various hemoglobins for oxygen and other gases and how it impacts oxygen transport.
- Describe the oxygen dissociation curve and the factors that affect it.
- Describe the inheritance patterns of genetic disorders of hemoglobin, with emphasis on sickle cell disease and thalassemia.
- Describe the worldwide epidemiology of sickle cell disease and thalassemia.
Global Objectives
Assessments
Concept Application Exercise (CAE)
Tags
Basic Sciences
Embryology
Epidemiology
Genetics
Curriculum Block
Hematology
Medical Foundation 2
Part 2
Week 2
Curriculum Week
Part 2
Week 5
Discipline
Genetics
Hematology
Longitudinal Discipline
Black Health
Genetics
Priority Groups
MCC Presentations
Anemia
Jaundice
Non-Articular Musculoskeletal Pain
MeSH
Analgesics, Opioid [D27.505.696.663.850.014.520]
Anemia, Hemolytic [C15.378.071.141]
Analgesics, Opioid [D27.505.954.427.040.325]
Analgesics, Opioid [D27.505.954.427.210.049]
Anemia, Hemolytic, Congenital [C16.320.070]
Anemia, Sickle Cell [C15.378.420.155]
Anemia, Sickle Cell [C16.320.070.150]
Back Pain [C23.888.592.612.107]
Back Pain [C23.888.646.172]
Bias, Implicit [F01.145.813.550.281]
Black or African American [M01.686.372.500]
Black People [M01.686.372]
Blood Protein Electrophoresis [E05.196.401.076]
Blood Transfusion [E02.095.135]
Electrophoresis [E05.196.401]
Erythrocyte Transfusion [E02.095.135.140.275]
Exchange Transfusion, Whole Blood [E02.095.135.469]
Genetic Diseases, Inborn [C16.320]
Hematologic Diseases [C15.378]
Hemoglobinopathies [C15.378.420]
Hemoglobins [D12.776.124.400]
Hemoglobins [D12.776.422.316.762]
Hydroxyurea [D02.948.395]
Jaundice [C23.888.885.375]
Pain Management [E02.745]
Pain Management [N04.590.607.500]
Racism [F01.145.813.629.625]
Thalassemia [C15.378.071.141.150.875]